PIQ — Proteomics International Laboratories Share News
0.000.00%
Last trade - 00:00- AU$19.82m
- AU$16.40m
- AU$3.37m
Australia Stock Exchange release from PROTEOMICS INTER : Proteomics identifies novel biomarkers for Asthma and COPD
Australia Stock Exchange release from PROTEOMICS INTER : PRE_NR Ends: 08:31:21
Australia Stock Exchange release from PROTEOMICS INTER : Unique panel of biomarkers identified for oesophageal cancer
Australia Stock Exchange release from PROTEOMICS INTER : December 2021 Quarterly Activities Report and Appendix 4C
Australia Stock Exchange release from PROTEOMICS INTER : PRE_NR Ends: 08:25:25
Australia Stock Exchange release from PROTEOMICS INTER : Change of Registry Address
Australia Stock Exchange release from PROTEOMICS INTER : PRE_NR Ends: 08:41:12
Australia Stock Exchange release from PROTEOMICS INTER : Proteomics secures major pharmacokinetic testing contract
Australia Stock Exchange release from PROTEOMICS INTER : Proteomics receives $1.2 million in R&D tax incentive
Australia Stock Exchange release from PROTEOMICS INTER : PRE_NR Ends: 08:25:32
Australia Stock Exchange release from PROTEOMICS INTER : Issue of Equity Incentives to Employees
Australia Stock Exchange release from PROTEOMICS INTER : Notification regarding unquoted securities - PIQ
Australia Stock Exchange release from PROTEOMICS INTER : Final Director's Interest Notice
Australia Stock Exchange release from PROTEOMICS INTER : Results of Annual General Meeting
Australia Stock Exchange release from PROTEOMICS INTER : AGM Chairman's Address and Investor Presentation
Australia Stock Exchange release from PROTEOMICS INTER : PRE_NR Ends: 12:21:22
Australia Stock Exchange release from PROTEOMICS INTER : FDA advises regulatory pathway for PromarkerD in US
Australia's Proteomics Int'l jumps most in 5 weeks on distribution deal in GB
Brief: Proteomics International Laboratories Says Signed A Distribution Agreement With Apacor Ltd